卵巢癌

  • ovarian cancer;Ovarian Carcinoma;EOC
卵巢癌卵巢癌
  1. 卵巢癌是女性常患的第六大癌症。

    Ovarian cancer is the sixth most common cancer contracted by women .

  2. 我们想清楚的是卵巢癌细胞是如何对这种叫顺铂的药产生抗药性。

    So we wanted to figure out how these ovarian cancer cells are becoming resistant to this drug called Cisplatin .

  3. 实际上,在70位女性中就有一位会被确诊为卵巢癌,在100位中就有一位会因此而死亡。

    In fact , one in 70 women will be diagnosed with ovarian cancer . One in 100 will die from it .

  4. 卵巢癌是大多数人所不了解的癌症之一,或者至少说没有怎么注意。

    So ovarian cancer is one of those cancers that most people don 't know about , or at least don 't pay that much attention to .

  5. 细胞色素c介导的半胱天冬氨酸蛋白酶-3活性改变与人卵巢癌顺铂耐药的关系

    Relationship between cytochrome c-mediated caspase-3 activity and chemoresistance in cisplatin-resistant human ovarian cancer cell lines

  6. 也可以破坏遗传性卵巢癌病毒染色体(DNA)。

    Also can damage the hereditary ovarian cancer virus chromosome ( DNA ) .

  7. 对13例卵巢癌超声检查法(US)和计算机断层摄影术(CT)的作用及局限性进行了讨论。

    Thirteen patients with malignant ovarian tumors were examined by US and CT , the roles and limitations were discussed .

  8. 抗癌宁E药物具有协同顺铂抑制肿瘤卵巢癌细胞作用。

    Kang Ai Ning E can associate with cisplatin to inhibit ovary tumor growth .

  9. 5-氮-2′-脱氧胞苷对人卵巢癌细胞凋亡及DNA错配修复基因表达的影响

    Effects of 5-aza-2 ' - deoxycytidine on apoptosis of ovarian cancer cells and on expression of mismatch repair genes

  10. 在卵巢癌中,P53基因的突变是最常见的基因改变之一。

    P53 gene is the most commonly mutated gene in ovarian tumors .

  11. As2O3对卵巢癌耐顺铂细胞珠的诱导凋亡作用

    Apoptosis of Drug-Resistant Ovarian Tumor Cell Strain Induced by Arsenic Trioxide

  12. 卵巢癌细胞凋亡和细胞倍性与p53基因突变的关系

    Relationship Between p53 Gene Mutation and Apoptosis and Cell Ploidy of Ovarian Carcinoma

  13. MTT比色分析法检测卵巢癌药物敏感性

    Detection of chemosensitivity of ovarian cancer with MTT colorimetric assay

  14. 卵巢癌中k-ras基因点突变及p53蛋白表达

    Expression of k-ras point mutation and p53 protein in ovarian carcinoma

  15. 这些表明,Notch信号通路在卵巢癌的发生过程中可能起癌基因作用。

    These reports hint that Notch signaling might play important roles in ovarian cancer .

  16. 结果37例卵巢癌经手术证实腹膜转移29例,CT发现23例,准确性79.3%(23/29)。

    Results Of 37 patients , metastatic peritoneal implanted deposits were surgically observed in 29 , of which CT detected 23 ( 79.3 % ) .

  17. PCNA表达水平对上皮性卵巢癌化疗效果的影响

    The Expression Level of PCNA to the Effect of Chemotherapy on Epithelial Ovarian Carcinoma

  18. 目的:探讨E钙黏素(ECad)在上皮性卵巢癌中的表达及临床意义。

    Objective : To study the expression of E ˉ cadherin ( E ˉ cad ) in epithelial ovarian carcinoma and its clinical significance .

  19. 通过检测、抑制VEGF,可能为卵巢癌的早期诊断、治疗开辟新的途径。

    Measurement and neutralization of VEGF activity may have clinical application in early diagnosis and therapy of ovarian carcinoma .

  20. 在卵巢癌中,顺铂引起的细胞凋亡是p53依赖的,p53的异常会导致卵巢癌的耐药。

    Cisplatin-induced apoptosis in ovarian cancer cells is p53 dependent . Abnormal p53 regulation can result in cisplatin-resistance in cancer .

  21. 用COX一2启动子构建的重组载体需经合理修饰后才可用于卵巢癌的基因治疗。

    With proper modification , COX-2 promoter is useful in gene therapy of ovarian cancers .

  22. 卵巢癌(ovariancancer,OC)是妇科肿瘤中致死率最高的肿瘤,严重威胁妇女的健康和生命。表观遗传学在卵巢癌研究中的进展越来越引起重视。

    Ovarian cancer is the highest mortality gynecological cancer , which has a serious threat to the health and lives of women .

  23. 目的探讨Fas相关磷酸酯酶1(FAP1)在卵巢癌发病中的作用。

    Objective To investigate the roles of Fas-associated phosphatase-1 ( FAP-1 ) in the pathogenesis of ovarian cancer .

  24. 目的:探讨肠外营养支持(PN)在进展期卵巢癌病人术后应用的效果。

    Objectives : To observe the influence of PN treatment on the postoperative patients of advanced ovarian cancer .

  25. 目的观察卵巢癌中核因子κB(NuclearfactorkappaB,NF-κB)在活化及抑制状态时多药耐药基因1表达产物P-糖蛋白(P-glycoprotein,P-gp)的表达情况,探讨二者之间的关系。

    Objective To investigate the expression of multidrug resistance gene 1 product P-glycoprotein ( P-gp ) when nuclear factor kappa B is induced or inhibited .

  26. 耐药性卵巢癌中CX43和P-gp的检测

    Detection of CX43 and P-gp in chemotherapy resistance ovarian carcinoma

  27. 目的探讨卵巢癌组织蛋白激酶C(PKC)和P糖蛋白(Pgp)表达及其临床意义。

    Objective To study the significance of protein kinase C ( PKC ) and P glycoprotein ( P gp ) in patients with ovarian cancer .

  28. 目的探讨卵巢癌组织中环氧合酶-2(COX-2)的表达及其临床意义。

    Objective To study the expression of cyclooxygenase-2 ( COX-2 ) in ovarian carcinoma and its relation to clinical behavior .

  29. SeO2对人卵巢癌耐药细胞株耐药性的影响

    Effect of Selenium Dioxide on Cisplatin Resistance in Ovarian Carcinoma Cell Line COC1 / DDP

  30. 卵巢癌~(99m)Tc-MIBI显像与化疗疗效的相关性

    Correlation Between ~ ( 99m ) Tc-MIBI Scintigraphy of Ovarian Cancer and Efficacy of Chemotherapy